Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

Thu, 17.09.2026       Aardvark Therapeutics

Dated chronology: from a $16.00 IPO in February 2025 to a Phase 3 pause and a full FDA clinical hold, a securities class action alleges Aardvark Therapeutics' ARD-101 safety representations unraveled while AARD shares fell to $4.57.NEW YORK, Sept. 17, 2026 /PRNewswire/ -- SueWallSt encourages investors who suffered losses in Aardvark Therapeutics,...